ZYUS Life Sciences Corporation

OTCPK:ZLSC.F Stock Report

Market Cap: US$46.7m

ZYUS Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:ZLSC.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Dec 24BuyUS$6,561Brent ZettlIndividual10,000US$0.67
06 Dec 24BuyUS$637John HyshkaIndividual1,000US$0.64
03 Dec 24BuyUS$6,426Brent ZettlIndividual10,000US$0.68
02 Dec 24BuyUS$1,500Brent ZettlIndividual2,500US$0.60
26 Aug 24BuyUS$111,212Richard HoytIndividual157,894US$0.70
26 Aug 24BuyUS$370,707Wayne BrownleeIndividual526,315US$0.70
26 Aug 24BuyUS$111,212John KnowlesIndividual157,894US$0.70
31 Jul 24SellUS$313,032Brent ZettlIndividual470,000US$0.67
29 Jan 24BuyUS$125,853Brent ZettlIndividual184,000US$0.68
29 Jan 24SellUS$125,853Brent ZettlIndividual184,000US$0.68

Insider Trading Volume

Insider Buying: ZLSC.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ZLSC.F?
Owner TypeNumber of SharesOwnership Percentage
Institutions155,4100.209%
Private Companies1,993,0282.68%
General Public32,243,71143.4%
Individual Insiders39,965,59253.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.5%.

Top Shareholders

Top 13 shareholders own 56.64% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
46.5%
Brent Zettl
34,605,073US$21.7m2.68%no data
5.08%
Wayne Brownlee
3,780,943US$2.4m16.2%no data
2.68%
Talent Oil and Gas Ltd.,
1,993,028US$1.3m0%no data
0.61%
John Knowles
452,613US$284.3k53.6%no data
0.49%
Charlotte Hepburn
363,231US$228.2k0%no data
0.42%
Richard Hoyt
309,002US$194.1k104%no data
0.21%
Ninepoint Partners LP
155,410US$97.6k0%0.01%
0.17%
Keith Carpenter
125,178US$78.6k0%no data
0.13%
Michelle Gursky
99,332US$62.4k0%no data
0.13%
Lionel de Chabris
96,508US$60.6k0%no data
0.1%
Scott Livingstone
74,112US$46.6k0%no data
0.066%
John Eagle
49,250US$30.9k0%no data
0.014%
John Hyshka
10,350US$6.5k10.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 13:48
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ZYUS Life Sciences Corporation is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Justin KeywoodStifel Canada
Andrew PartheniouStifel Canada